Posted On: 10/09/2013 9:16:38 AM
Post# of 47

MFTH's patented technology is a medical assembly with a locking mechanism that is intended to ensure the substance cannot be released from the hypodermic needle without positive pre-matching
between the substance and its intended patient.
What's unique is that MFTH's protector device has a locking mechanism that ensures substance is only released from the hypodermic needle after positive technology-based pre-matching is used with the specific patient, using barcode technology.
Using a barcode reader, the device confirms that the medication and dosage contained within a syringe are correctly intended for a medical patient. Upon electronic confirmation, the syringe locking-device opens, allowing for the administration of the syringe's contents.
between the substance and its intended patient.
What's unique is that MFTH's protector device has a locking mechanism that ensures substance is only released from the hypodermic needle after positive technology-based pre-matching is used with the specific patient, using barcode technology.
Using a barcode reader, the device confirms that the medication and dosage contained within a syringe are correctly intended for a medical patient. Upon electronic confirmation, the syringe locking-device opens, allowing for the administration of the syringe's contents.

